Alfred Sandrock Biogen Inc. (BIIB) insider trading activity

BIIB Quotes by TradingView

Alfred Sandrock is Head of Research & Development of BIOGEN INC.. Currently has a direct ownership of 10,169 shares of BIIB, which is worth approximately $2.33 Million. The most recent transaction as insider was on Jun 07, 2021, when has been sold 7,672 shares (Common Stock) at a price of $440.0 per share, resulting in proceeds of $3,375,680. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.2K
0% 3M change
0% 12M change
Total Value Held $2.33 Million

Alfred Sandrock Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 07 2021
SELL
Open market or private sale
$3,375,680 $440.0 p/Share
7,672 Reduced 43.0%
10,169 Common Stock
Feb 12 2021
SELL
Payment of exercise price or tax liability
$975,885 $278.03 p/Share
3,510 Reduced 16.52%
17,738 Common Stock
Feb 12 2021
BUY
Exercise of conversion of derivative security
-
4,454 Added 18.43%
19,715 Common Stock
Jan 27 2021
BUY
Grant, award, or other acquisition
-
3,728 Added 18.17%
16,794 Common Stock
Nov 04 2020
SELL
Open market or private sale
$525,000 $350.0 p/Share
1,500 Reduced 10.3%
13,066 Common Stock

Also insider at

VYGR
Voyager Therapeutics, Inc. Healthcare
President and CEO
AS

Alfred Sandrock

Head of Research & Development
Cambridge, MA

Track Institutional and Insider Activities on BIIB

Follow BIOGEN INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIIB shares.

Notify only if

Insider Trading

Get notified when an Biogen Inc. insider buys or sells BIIB shares.

Notify only if

News

Receive news related to BIOGEN INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BIIB